Correlation Between Gilead Sciences and Atea Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Atea Pharmaceuticals, you can compare the effects of market volatilities on Gilead Sciences and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Atea Pharmaceuticals.
Diversification Opportunities for Gilead Sciences and Atea Pharmaceuticals
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Gilead and Atea is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Atea Pharmaceuticals go up and down completely randomly.
Pair Corralation between Gilead Sciences and Atea Pharmaceuticals
Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.77 times more return on investment than Atea Pharmaceuticals. However, Gilead Sciences is 1.29 times less risky than Atea Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Atea Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest 8,876 in Gilead Sciences on August 29, 2024 and sell it today you would earn a total of 259.00 from holding Gilead Sciences or generate 2.92% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gilead Sciences vs. Atea Pharmaceuticals
Performance |
| Timeline |
| Gilead Sciences |
| Atea Pharmaceuticals |
Gilead Sciences and Atea Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gilead Sciences and Atea Pharmaceuticals
The main advantage of trading using opposite Gilead Sciences and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.| Gilead Sciences vs. Pharvaris BV | Gilead Sciences vs. Brinker International | Gilead Sciences vs. Alcoa Corp | Gilead Sciences vs. Direxion Daily FTSE |
| Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |